AI assistant
Moderna, Inc. — Director's Dealing 2025
May 29, 2025
30610_dirs_2025-05-29_6de788b7-6ba4-4ecb-a15c-e985075e92e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-05-27
Reporting Person: Mock James M (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-27 | Common Stock | M | 773 | — | Acquired | 16396 | Direct |
| 2025-05-27 | Common Stock | F | 374 | $26.26 | Disposed | 16022 | Direct |
| 2025-05-28 | Common Stock | M | 328 | — | Acquired | 16350 | Direct |
| 2025-05-28 | Common Stock | F | 159 | $26.76 | Disposed | 16191 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-05-27 | Restricted Stock Units | $ | M | 773 | Disposed | Common Stock (773) | Direct | |
| 2025-05-28 | Restricted Stock Units | $ | M | 328 | Disposed | Common Stock (328) | Direct |
Footnotes
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F4: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.